11/27/2024
3:44 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
4:19 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
8:55 AM | Denali Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Denali Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
3:39 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:30 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
| Form SC 13G/A | |
|
10/18/2024
3:19 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
3:37 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:25 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:25 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
5:26 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:14 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:14 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:15 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:16 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
3:40 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:42 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:08 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:08 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:09 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:09 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:27 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
12:18 PM | Denali Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
08/15/2024
3:10 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
7:36 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
7:37 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
5:52 AM | Denali Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
5:48 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
8:13 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
8:13 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
3:38 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
3:43 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
7:06 PM | Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:31 PM | Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:32 PM | Denali Therapeutics (Issuer)
Thornberry Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:33 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:20 PM | Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:27 PM | Denali Therapeutics (Issuer)
Harris Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:28 PM | Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:29 PM | Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
How Low-Cost Stocks Generate Monthly Income (Ad) Are you ready to transform your investment strategy and generate a steady monthly income?
We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE! 👉 Yes, I Want the Free Report! 👈 |
06/04/2024
5:30 PM | Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:30 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:01 PM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
4:14 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:32 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
5:07 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:59 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:01 PM | Denali Therapeutics (Filer)
| Form S-3ASR | |
03/01/2024
3:51 PM | Denali Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/27/2024
7:03 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
7:07 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
4:38 PM | Denali Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:38 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
7:02 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
8:14 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
8:14 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
8:15 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
8:16 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:43 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:22 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:17 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:18 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:19 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
6:07 PM | BIOGEN INC. (Filed by)
Denali Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
5:59 AM | BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
5:40 AM | Denali Therapeutics (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
| Form SC 13G/A | |
01/18/2024
5:26 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:23 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
7:18 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:28 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:09 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
6:34 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:35 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:33 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:34 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:20 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:06 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
7:25 PM | Denali Therapeutics (Subject)
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:27 PM | Denali Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:27 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:21 PM | Denali Therapeutics (Subject)
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:23 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
4:57 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
4:57 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
4:56 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
